Filter
1993
Text search:
Neglected
Diseases
Featured
Recommendations
181
New Publications
387
Language
Document type
No document type
767
Studies & Reports
544
Guidelines
193
Resource Platforms
105
Strategic & Response Plan
102
Manuals
83
Fact sheets
73
Videos
41
Training Material
21
Infographics
20
Online Courses
16
Situation Updates
10
Brochures
9
Dashboards/Maps
7
App
2
Countries / Regions
Global
248
India
52
Latin America and the Carribbean
47
Africa
38
Sierra Leone
35
Liberia
32
Ethiopia
31
Uganda
31
Kenya
29
Bangladesh
27
Tanzania
25
Western and Central Europe
23
Rwanda
21
South Africa
21
Malawi
20
Nepal
18
Ghana
17
Syria
17
Brazil
16
Congo, Democratic Republic of
15
South Sudan
14
Zambia
14
South–East Asia Region
14
Asia
14
Mozambique
13
West and Central Africa
13
Nigeria
12
Namibia
11
Colombia
11
East and Southern Africa
11
Guinea
10
Yemen
10
Eastern Europe
10
Myanmar / Burma
9
Middle East and North Africa
9
Philippines
8
Cameroon
7
Indonesia
7
Sudan
7
Somalia
6
Lesotho
6
Venezuela
6
Pakistan
5
Germany
5
Ukraine
5
Botswana
5
North America
5
Zimbabwe
4
Jordan
4
Afghanistan
4
Angola
4
Eastern Europe and Central Asia
4
Haiti
3
Iraq
3
Paraguay
3
Albania
3
Tajikistan
3
Burkina Faso
2
Saudi Arabia
2
Lebanon
2
Turkey
2
Egypt
2
Chad
2
China
2
Benin
2
Peru
2
Eswatini/ Swaziland
2
El Salvador
2
Bolivia
2
Madagascar
2
Southern Africa
2
Russia
2
Iran
2
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Togo
1
Cambodia
1
Thailand
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Dominican Republic
1
North Macedonia
1
Honduras
1
Greece
1
Libya
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Poland
1
Palestine
1
Italy
1
Djibouti
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Georgia
1
Vietnam
1
France
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
465
Clinical Guidelines
186
Public Health
136
Key Resources
78
Women & Child Health
63
Pharmacy & Technologies
30
Capacity Building
27
Annual Report MEDBOX
1
Toolboxes
NTDs
711
Mental Health
89
HIV
85
Planetary Health
76
TB
68
Global Health Education
62
COVID-19
57
Disability
53
Ebola & Marburg
38
Conflict
32
Caregiver
31
Health Financing Toolbox
30
NCDs
30
AMR
27
Malaria
24
Rapid Response
21
Pharmacy
19
Refugee
17
Cholera
12
Zika
12
Natural Hazards
10
Social Ethics
10
Polio
7
2.0 Rapid Response
7
Specific Hazards
3
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
Diabetes Poster - Does your child show any of these symptoms?
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom
...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported
...
Chagas Disease (CD) affects 6–7 million people worldwide and isrelated topoverty-promo ting conditions. Chronic asymptomatic cases are mostly invisible tohealth systems. Aiming totranslate CD discoveries into education/information practices toraise alertness and empowerment ofaffected people; and
...
A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations s
...
Leptospirosis is a bacterial zoonotic disease of worldwide importance, though relatively neglected in many African countries including sub Saharan Africa that is among areas with high burden of this disease. The disease is often mistaken for other f
...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec
...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu
...
Scabies is a global health concern disproportionately affecting vulnerable populations such as refugees and asylum seekers. Greece is a main point of entry in Europe for refugees, but epidemiological data on scabies in this population are scarce. We aimed to describe the epidemiology of scabies, inc
...
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address
the many outstanding rese
...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical
...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable t
...
DNDi’s long-term goal for sleeping sickness, also known as human African trypanosomiasis (HAT), is to develop and register two new drugs that are effective against both Stage 1 and Stage 2 of the disease and both subspecies of the parasite, T.b. gambiense and T.b. rhodesiense. T.b. rhodesiense is
...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies
...
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.
...
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin.
The only treatment available for cutaneous leishmaniasis is high
...
La enfermedad de Chagas es parasitaria y afecta a más de 6 millones
de personas en el mundo. Como normalmente es asintomática durante
años, los nuevos casos suelen no detectarse ni reportarse y la mayoría
de las personas con la enfermedad no tiene conciencia de su condición.
Se diagnostica
...
This is a summary of the following peer-reviewed, scientific article:
Comparative Evaluation of Immunoassays to Improve Access to Diagnosis for Chagas Disease in Colombia.
